Injectables1 September 2026

A Randomized Trial of Lower-Face Neuromodulator Dosing

A randomized, double-blind trial in the Aesthetic Surgery Journal mapped injection points and escalating doses for botulinum toxin in the lower face. The lower face is where the muscles are doing more work than most people realize, and where a few units in the wrong place changes a smile rather than a line. Mapped dosing studies are how that becomes a technique rather than an individual injector's preference.

Tagged: Neuromodulator · Evidence

Newsletter

The one email a week that isn't selling you something.

What changed in facial rejuvenation this week, one guide we updated, and why it matters. Written by Jay Keni, MD.

A weekly email, once we launch it. We don’t sell or share addresses, and we never add patients from practice records — privacy.